Abbott reports first-quarter 2023 results; increases outlook for underlying base business

Sales of $9.7 billion driven by strong underlying base business performance reported sales decreased 18.1 percent due to anticipated decline in covid-19 testing-related sales versus prior year organic sales growth for underlying base business of 10.0 percent, led by medical devices, established pharmaceuticals and nutrition abbott park, ill., april 19, 2023 /prnewswire/ -- abbott (nyse: abt) today announced financial results for the first quarter ended march 31, 2023.
ABT Ratings Summary
ABT Quant Ranking